|
MANBA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25239996151549E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.09383679470466E-13 |
| Normal-vs-Stage2 |
3.215900E-03 |
| Normal-vs-Stage3 |
2.698700E-03 |
| Normal-vs-Stage4 |
2.019700E-02 |
| Stage1-vs-Stage2 |
9.875900E-02 |
| Stage1-vs-Stage3 |
3.360600E-04 |
| Stage1-vs-Stage4 |
3.461200E-03 |
| Stage2-vs-Stage3 |
3.526800E-01 |
| Stage2-vs-Stage4 |
4.623000E-01 |
| Stage3-vs-Stage4 |
9.799400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.7036999850647E-09 |
| Normal-vs-AfricanAmerican |
1.801550E-04 |
| Normal-vs-Asian |
4.457000E-03 |
| Caucasian-vs-AfricanAmerican |
5.163000E-01 |
| Caucasian-vs-Asian |
6.928000E-01 |
| AfricanAmerican-vs-Asian |
8.979200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.97819996336801E-09 |
| Normal-vs-Female |
2.26780000001092E-07 |
| Male-vs-Female |
5.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.775200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.48069999992029E-08 |
| Normal-vs-Age(61-80Yrs) |
2.31459995614358E-09 |
| Normal-vs-Age(81-100Yrs) |
7.375700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.201790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.238200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.949400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.593400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.386400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.570570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.559400E-03 |
| Normal-vs-Grade 2 |
9.13110032030318E-10 |
| Normal-vs-Grade 3 |
3.53689999954554E-07 |
| Normal-vs-Grade 4 |
5.638100E-02 |
| Grade 1-vs-Grade 2 |
1.829600E-02 |
| Grade 1-vs-Grade 3 |
1.135620E-02 |
| Grade 1-vs-Grade 4 |
2.555300E-03 |
| Grade 2-vs-Grade 3 |
3.507600E-01 |
| Grade 2-vs-Grade 4 |
1.043620E-02 |
| Grade 3-vs-Grade 4 |
7.440000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.93700000483688E-09 |
| Normal-vs-ccB subtype |
5.36780000448545E-08 |
| ccA subtype-vs-ccB subtype |
8.389600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.55649995512175E-09 |
| Normal-vs-N1 |
1.920760E-01 |
| N0-vs-N1 |
7.731000E-01 |
|
|
